Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / VTGN - VistaGen Therapeutics GAAP EPS of -$0.08


VTGN - VistaGen Therapeutics GAAP EPS of -$0.08

  • VistaGen Therapeutics press release ( NASDAQ: VTGN ): Q2 GAAP EPS of -$0.08.
  • At September 30, 2022, the Company had cash and cash equivalents of approximately $35.3 million.
  • "As a result of the conclusion of certain clinical trial activity and deferral of several research and development and pre-commercialization activities, the Company anticipates a decrease in spending over the next few quarters which the Company expects will extend its cash runway through a series of potential key milestones and data readouts in 2023," report.

For further details see:

VistaGen Therapeutics GAAP EPS of -$0.08
Stock Information

Company Name: VistaGen Therapeutics Inc.
Stock Symbol: VTGN
Market: NASDAQ
Website: vistagen.com

Menu

VTGN VTGN Quote VTGN Short VTGN News VTGN Articles VTGN Message Board
Get VTGN Alerts

News, Short Squeeze, Breakout and More Instantly...